For instance, a previous study reported that bone metastases were a significant independent negative predictive factor for OS in lung cancer patients with mutated and wild-type EGFR, whereas lung or brain metastases were not associated with OS, highlighting the importance of managing bone metastasis [6]. This evidence concerns the gene EGFR and lung carcinoma.